Core Viewpoint - Tianan Health (00383) announced a share buyback plan, intending to repurchase 1.145 million shares at a cost of HKD 1.145 million [1] Group 1 - The company will execute the buyback on November 19, 2025 [1] - The total expenditure for the buyback is set at HKD 1.145 million [1] - The number of shares to be repurchased is 1.145 million [1]

Core Viewpoint - Tianan Health (00383.HK) announced a share buyback on November 19, spending HKD 1.145 million to repurchase 1.145 million shares at a price of HKD 1 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 1.145 million shares at a total cost of HKD 1.145 million [1]

Core Viewpoint - Tianan Health (00383) announced a share buyback plan, intending to repurchase 15,000 shares at a cost of HKD 15,000 on November 18, 2025 [1] Summary by Category - **Company Actions** - The company plans to spend HKD 15,000 to buy back 15,000 shares [1]

Group 1 - The company Tianan Health (00383.HK) announced a share buyback on November 18, spending HKD 15,000 to repurchase 15,000 shares at a price of HKD 1 per share [1]

Core Viewpoint - The company has obtained a pharmaceutical business license for its wholly-owned subsidiary, Shandong Weiming Tianan Pharmaceutical Co., Ltd., allowing it to operate in various pharmaceutical sectors [1] Group 1 - The license was issued by the Shandong Provincial Drug Administration [1] - The approved business scope includes traditional Chinese medicine pieces, Chinese patent medicines, chemical drugs, and biological products (excluding vaccines) [1] - The license also covers the operation of refrigerated and frozen pharmaceuticals [1]

Group 1 - The company Tianan Health (00383) announced a share buyback plan [1] - The total amount allocated for the buyback is HKD 75,000 [1] - The company plans to repurchase 75,000 shares at a price of HKD 1 per share [1]

Core Viewpoint - Tianan Health (00383.HK) announced a share buyback of 75,000 shares at a cost of HKD 75,000 on November 17 [1] Summary by Category - **Company Actions** - The company executed a buyback of 75,000 shares, indicating a commitment to enhancing shareholder value [1]

Group 1 - The company Tianan Health (00383) announced a share buyback plan [1] - The total amount allocated for the buyback is HKD 75,000 [1] - The company plans to repurchase 75,000 shares at a price of HKD 1 per share [1]

Core Viewpoint - Tianan Health (00383) has announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a total cost of RMB 130 million [1] Group 1: Agreement Details - The renovation agreement is between Kunming Tongren Hospital Co., Ltd. and Zhejiang ShunJie Construction Group Co., Ltd. [1] - The scope of the renovation includes the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building, covering a total construction area of approximately 48,357 square meters [1] Group 2: Management's Perspective - The board believes that the transaction under the renovation agreement is conducted on normal commercial terms [1] - The terms of the renovation agreement are considered fair and reasonable [1] - Entering into the renovation agreement is in the overall interest of the company and its shareholders [1]

Core Viewpoint - Tianan Health (00383.HK) announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a contract value of RMB 129.8 million, to be executed by Zhejiang Shunjie Construction [1] Group 1: Project Details - The renovation agreement includes the decoration and renovation of the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building [1] - Zhejiang Shunjie Construction has been the general contractor for the civil engineering of the second phase of Kunming Tongren Hospital, and the collaboration has been satisfactory [1] Group 2: Strategic Importance - The selection of the contractor for the renovation work aims to ensure a smooth continuation of the project following the completion of the civil engineering phase [1]